bedaquiline dosage

Bedaquiline (Bedaquiline), as an important drug in the treatment of multidrug-resistant tuberculosis (MDR-TB) and drug-resistant tuberculosis, its dose control is crucial to the treatment effect. Different patients and different stages of treatment require different dosages.

For adult patients, the dosing regimen for bedaquiline is clear. In the initial stage of treatment, that is, the first two weeks, in order to quickly control the condition, patients need to take 400 mg orally once a day (equivalent to 4 100 mg tablets). At this stage, the drugs will be fully exerted to effectively inhibit the spread of germs. After entering the maintenance phase, the dose is halved to 200 mg three times a week for 22 weeks. This stage aims to consolidate the efficacy and reduce bacterial resistance.

It is important to note that bedaquiline should be used with caution in children. Due to insufficient safety data, it is not recommended for children under the age of 18 unless doctors fully weigh the risks and benefits based on special medical needs.

To ensure drug absorption and improve therapeutic effect, bedaquiline should be taken with meals. Patients must follow the doctor's instructions, take the medicine on time and in the right amount, and avoid missing doses or adjusting the dosage on their own to avoid affecting the efficacy or increasing the risk of side effects.

For patients with hepatic and renal insufficiency, dose adjustment is particularly critical. Those with severe liver and kidney dysfunction need to reduce the dose or strengthen monitoring under the guidance of a doctor to ensure treatment safety. Elderly patients, especially those with other complications, need to be more cautious when using bedaquiline, and the dosage and monitoring frequency may need to be flexibly adjusted according to the specific situation.

The treatment cycle of bedaquiline is usually longer, lasting 24 weeks (6 months). However, the specific course of treatment requires a comprehensive judgment by the doctor based on the patient's condition, treatment response and drug resistance. During treatment, patients should maintain close communication with their doctors and provide timely feedback on the treatment situation so that doctors can adjust dosage or treatment plans according to their condition.